Slowing growth in China weighed the markets down during the midday with the Dow slipping 24 points to 17,191. Nasdaq lost 8 points to 4,878.
On the upside
Shares of Keryx Biopharmaceuticals (Nasdaq: KERX) extended its gains.
Northwest Biotherapeutics (Nasdaq: NWBO) issued a statement saying that it was unaware of any reason for the sharp drop in its stock price on Friday.
Bargain hunters lifted shares of Zafgen (Nasdaq: ZFGN).
On the downside
Great Lakes Dredge & Dock (Nasdaq: GLDD) withdrew its full year earnings outlook and initiated a review of strategic alternatives to increase shareholder value.
Investors locked in profits on PTC Therapeutics (Nasdaq: PTCT).
A beta-thalassemia patient treated with the first generation version of Bluebird Bio’s (Nasdaq: BLUE) gene therapy suffered a relapse.
In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on the NYSE while advancers edged out decliners by more than 5 to 4 on Nasdaq. The broader S&P 500 lost 2 points to 2,030. Bitcoin added $2 to $262.
